BFA
IMGN

BlackRock Fund Advisors’s Immunogen Inc IMGN Stock Holding History

BlackRock Fund Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$5.13M Sell
2,514,221
-796,516
-24% -$1.6M ﹤0.01% 2920
2016
Q3 		$8.87M Buy
3,310,737
+199,247
+6% +$579K ﹤0.01% 2540
2016
Q2 		$9.58M Sell
3,111,490
-82,805
-3% -$519K ﹤0.01% 2428
2016
Q1 		$27.2M Buy
3,194,295
+61,325
+2% +$519K 0.01% 1814
2015
Q4 		$42.5M Sell
3,132,970
-148,447
-5% -$1.83M 0.01% 1584
2015
Q3 		$31.5M Buy
3,281,417
+105,188
+3% +$1.54M 0.01% 1722
2015
Q2 		$45.7M Sell
3,176,229
-99,241
-3% -$1.09M 0.01% 1582
2015
Q1 		$29.3M Buy
3,275,470
+95,256
+3% +$690K 0.01% 1853
2014
Q4 		$19.4M Buy
3,180,214
+259,033
+9% +$2.37M ﹤0.01% 2084
2014
Q3 		$30.9M Sell
2,921,181
-12,235
-0.4% -$138K 0.01% 1669
2014
Q2 		$34.8M Sell
2,933,416
-252,272
-8% -$3.17M 0.01% 1652
2014
Q1 		$47.6M Buy
3,185,688
+88,783
+3% +$1.4M 0.01% 1451
2013
Q4 		$45.4M Sell
3,096,905
-49,722
-2% -$764K 0.01% 1466
2013
Q3 		$53.6M Buy
3,146,627
+404,777
+15% +$7.12M 0.02% 1277
2013
Q2 		$45.5M Buy
+2,741,850
New +$44.4M 0.02% 1278

Other funds holding IMGN

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock Fund Advisors's IMGN Position: Q4 2016 in Review

BlackRock Fund Advisors reduced its Immunogen Inc (IMGN) stake by 24% in Q4 2016, selling an estimated $1.6M and leaving 2,514,221 shares worth $5.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2920.

BlackRock Fund Advisors first reported a position in IMGN in Q2 2013 and has held it in 15 quarters since. The position peaked at $53.6M in Q3 2013. 156 funds tracked by Wall St. Rank hold IMGN as of Q4 2016.

  • BlackRock Fund Advisors held 2,514,221 shares of Immunogen Inc worth $5.13M as of Q4 2016.
  • BlackRock Fund Advisors sold 796,516 Immunogen Inc shares in Q4 2016, an estimated $1.6M.
  • Immunogen Inc made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2920 holding.
  • BlackRock Fund Advisors first reported a position in Immunogen Inc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Immunogen Inc position peaked at $53.6M in Q3 2013.
  • 156 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.